Tumori Journal

Papers
(The median citation count of Tumori Journal is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Effect of body mass index on immune checkpoint inhibitor efficacy in patients with advanced cancer52
Small tongue squamous cell carcinoma with neck metastasis at diagnosis: operative insights and surgical technique35
A new era for bladder cancer: Enfortumab vedotin and pembrolizumab milestone approval25
Stereotactic body radiotherapy in oligoprogressive metastatic castration-resistant prostate cancer during abiraterone or enzalutamide24
Fertility and abortion: A population-based comparison between women with cancer and those in childbearing age23
Impact of the STK11/KRAS co-mutation on the response to immunotherapy in a real-world pan-cancer cohort22
Combined CAR-T/HSCT approach in a patient with refractory acute lymphoblastic leukemia and cystic fibrosis20
Fertility preservation strategies for patients with lymphoma: a real-world practice survey among Fondazione Italiana Linfomi centers15
PARK7/DJ-1 inhibition decreases invasion and proliferation of uveal melanoma cells13
Delta-volume radiomics of induction chemotherapy to predict outcome of subsequent chemoradiotherapy for locally advanced hypopharyngeal cancer12
Blooming in the rain12
Chemo-surgical approach in vulvar leiomyosarcoma: A case report11
Is motherhood still possible after pelvic carbon ion radiotherapy? A promising combined fertility-preservation approach11
Universal testing for COVID-19 in patients undergoing cancer treatment during the second outbreak in Brescia11
Apalutamide or enzalutamide in castration-sensitive prostate cancer: a number needed to treat analysis10
Oral vinorelbine in young patients with desmoid-type fibromatosis9
Biomarker testing implementation for molecularly targeted therapy in non-small cell lung cancer patients9
“Based on a true story” podcast: a journey into the world of young patients with cancer9
Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study8
Advances in spatial multi-omics in tumors7
Enhanced patient journey associated with improved overall survival in colon cancer patients: A study by the Ligurian Oncology Network7
Role and evaluation of pathologic response in early breast cancer specimens after neoadjuvant therapy: consensus statement7
Ongoing discussion: Is prophylactic central neck dissection necessary in c T 1a-b,2 N 0 papilla7
Humanistic nursing combined with Neuman’s nursing in the application for oncology patients7
Role of enhancement modifications in evaluating tumor response to immunotherapy in metastatic renal cell carcinoma7
Prognostic value of Aurora B expression in cancer patients: A meta-analysis6
Emerging therapeutic strategies in Lynch syndrome-associated colorectal cancer and the role of MMR testing6
Expression of concern6
Time trends of cancer incidence in young adults (20-49 years) in Italy. A population - based study, 2008-20176
Association between EGFR mutation types and incidence of brain metastases in postoperative patients with stage I–III NSCLC5
Periprosthetic effusions surrounding breast expander: a flow cytometric, immunohistochemical and molecular characterization5
Volumetric staging in radiotherapy for oropharyngeal cancers5
Predicting acute severe toxicity for head and neck squamous cell carcinomas by combining dosimetry with a radiosensitivity biomarker: a pilot study5
Paraneoplastic neurological syndromes in patients affected by SCLC: a case series5
ESCO1 as a novel predictive biomarker and potential therapeutic target in renal cell carcinoma5
Adherence to oral hormonal anticancer agents in breast cancer5
Quality assurance for cancer patient safety: Clinical assessment for precise angles in linac during radiation therapy5
Outcomes of chemotherapy/chemoradiation vs. R2 surgical debulking vs. palliative care in nonresectable locally recurrent rectal cancer5
Effect of anti-inflammatory molecules from food on organoids derived from adenomatous polyps of FAP subjects5
Outcomes of SARS-CoV-2 infection in cancer versus non-cancer-patients: a population-based study in northeastern Italy5
BONSAI-2 study: Nivolumab as therapeutic option after cabozantinib failure in metastatic collecting duct carcinoma patients5
Personalized treatment using predictive biomarkers in solid organ malignancies: A review5
Vaginal cancer treated with curative radiotherapy with or without concomitant chemotherapy: oncologic outcomes and prognostic factors4
Clinical heterogeneity and reduced penetrance in DICER1 syndrome: a report of three families4
Corrigendum to: AIRO Breast Cancer Group Best Clinical Practice 2022 Update4
Impact of low skeletal muscle mass in oropharyngeal cancer patients treated with radical chemo-radiotherapy: A mono-institutional experience4
Breast cancer and large-cell neuroendocrine carcinoma harboring the same PIK3CA mutation: A case report4
KRAS inhibitors in drug resistance and potential for combination therapy4
Hippocampal region avoidance in whole brain radiotherapy in brain metastases: For all or for some? A real-world feasibility report4
Current practices of follow-up programs for childhood cancer survivors in Italy4
Comparative analysis of the quantitative parameter method and elasticity color mode method for real-time shear wave elastography in the diagnosis of benign and malignant solid breast lesions4
Chemoprevention strategies in hereditary breast and ovarian cancer syndromes4
15th BGICC Abstract Book 20234
Self-perceived attitudes of Italian oncology nurses towards clinical trial involvement: A cohort observational study4
Secular trends in incidence and mortality of non-Hodgkin’s lymphoma in China, 1990–2019, and predictions to 2030: Outlook for the future burden of disease4
Prolonged COVID-19 infection in a child with lymphoblastic non-Hodgkin lymphoma: which is the best management?4
Outcome of non-small-cell lung cancer with driven mutations treated with anti-PD-(L)1 agents: A systematic review3
Response to lorlatinib rechallenge in a case of ALK-rearranged metastatic NSCLC with a resistance mutation to second generation TKIs3
A locally advanced colon cancer patient with Muir-Torre syndrome obtains durable response to neoadjuvant and adjuvant immunotherapy3
BGICC Conference Abstract Book 20223
Successful treatment of multiple relapsed–refractory Langerhans cell histiocytosis with cyclosporine3
AIOM Abstract3
CtDNA-guided rechallenge with anti-EGFR therapy in RASwt metastatic colorectal cancer: Evidence from clinical practice3
End-of-Life transfusion support at hospice and pediatric oncology unit: Bridging the gap between benefits and therapeutic alliance3
ERBB2 mutation landscape in non-small cell lung cancer patients in Northeast China3
Validating HER2 copy number variation assessment by NGS: A comparative analysis with immunohistochemistry and in situ hybridization3
Prolonged responses to brentuximab vedotin as last therapy in Hodgkin lymphoma failing autologous transplantation: A case series3
Differences in clinical features and prognosis between orbit adenoid cystic carcinoma and adenocarcinoma: a study from the SEER 18 database3
Carcinomatosis under control by osimertinib in EGFR and TP53 mutated lung adenocarcinoma3
I was only sixteen3
A single-center experience with giant cell tumors of sphenoid bone and clivus3
Efficacy and safety of PD-1 inhibitor plus chemotherapy in advanced nasopharyngeal carcinoma: A meta-analysis3
Advancing biomarker development for diagnostics and therapeutics using solid tumour cancer stem cell models3
Breast implant associated anaplastic large cell lymphoma: Evidence for an efficient diagnostic workup3
Increased expression of FGF14 and SCN2A/SCN11A is associated with better survival of HCC patients3
COVID-19 immunization in people with cancer—Is it safe and efficient? What do we know?3
Central venous catheters-related-thrombosis and risk factors in oncological patients: A retrospective evaluation of recent risk scores3
Italian translation, cultural adaptation and pilot testing of Psychosocial Assessment Tool (PAT 3.1) in pediatric cancer3
Italian oncologists and vaccinations against infectious diseases: Results of a survey of the Italian Association of Medical Oncology3
Immunogenicity of radiotherapy on bone metastases from prostate adenocarcinoma: What is the future for the combination with radiotherapy/immunotherapy?3
MLH1 promoter hypermethylation and Lynch Syndrome: When to test for constitutional epimutations of MLH1 gene?3
Multiple targets, germline BRCA1 mutation and HRD in a lung cancer patient: Molecular considerations and treatment decision-making3
The digital revolution in pathology: Towards a smarter approach to research and treatment3
Update on radioligand therapy with 177Lu-PSMA for metastatic castration-resistant prostate cancer: clinical aspects and survival effects2
Mediastinal lymph node removal ameliorates cytotoxic T-lymphocyte functions in patients with non-small cell lung cancer2
Transient asymptomatic pulmonary opacities and interstitial lung disease in EGFR-mutated non-small cell lung cancer treated with osimertinib2
Biomedical omics: first insights of a new MSc degree of the University of Milan2
Cytokine release syndrome after CAR infusion in pediatric patients with refractory/relapsed B-ALL: is there a role for diclofenac?2
Patient-reported outcome measurements in post-mastectomy implant-based breast reconstruction and radiotherapy: Analysis of BREAST-Q data2
Factors influencing the colorectal surveillance adherence in Lynch Syndrome: A retrospective monocentric study2
Risk factors for primary site necrosis after definitive concurrent chemoradiotherapy in head and neck cancer2
Corrigendum to “Self-perceived attitudes of Italian oncology nurses towards clinical trial involvement: A cohort observational study”2
Management of primary and recurrent Bartholin’s gland carcinoma: A systematic review on behalf of MITO Rare Cancer Group2
Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund2
Melanoma and sex hormones: Pathogenesis, progressive disease and response to treatments2
Retroperitoneal lymph-node dissection (RPLND) as upfront management in stage II germ-cell tumours: Evaluation of safety and efficacy2
Neoadjuvant or adjuvant immunotherapy in bladder cancer: biological opportunity or clinical utility?2
Have we made progress in taking care of adolescents and young adults with cancer? Results of a European multi-professional survey2
Alk-rearranged lung adenocarcinoma: From molecular genetics to therapeutic targeting2
Risk-based breast cancer screening: What are the challenges?2
Implementation of a MSRE ddPCR method for the detection of methylated WIF1 and NPY genes in colorectal cancer patients2
De novo germline pathogenic variant in Lynch Syndrome: A rare event or the tip of the iceberg?2
A shared vaccination ambulatory for patients with cancer in Udine, Italy2
The power of art and the powers of adolescents with cancer: Age-specific projects at Italian pediatric oncology centers2
Impact of inter-observer variability on first axillary level dosimetry in breast cancer radiotherapy: An AIRO multi-institutional study2
Associations between vascular endothelial growth factor polymorphisms and response to 5-FU-based pharmaceutical therapy in esophageal squamous cell carcinoma: A meta-analysis2
The efficacy and safety of anlotinib for subsequent line treatment of small cell lung cancer: a systematic review and meta-analysis1
Nomogram predicts the prognosis of patients with thymic carcinoma: A population-based study using SEER data1
Complete pathological response of hormone receptor positive invasive breast cancer in a patient with multiple myeloma treated with ixazomib1
Contrast-enhanced digital mammography and magnetic resonance imaging: reproducibility compared to pathologic anatomy1
The impact of the new European CTR on academic clinical research: A survey by the Italian Sarcoma Group Federated Trial Centre1
AIOM Abstract1
Patients with brain metastases from gastric cancer1
A homogeneous treatment for non-DIPG diffuse midline glioma1
Adjuvant chemotherapy in elderly patients with HER2-negative early breast cancer: A systematic review and meta-analysis1
Clinicopathological characteristics and prognosis of cervical adenocarcinoma across diverse histological subtypes1
Electronic cigarette, or vaping, product use-associated lung injury (EVALI) in a patient with testicular cancer: A case report1
The role of diet as adjuvant treatment in FAP patients1
Exploratory analysis of the professional quality of life in an Italian radiotherapy department: The role of empathy and alexithymia1
A five-year review of chemoradiotherapy practice in anal cancer: Radiotherapy audit results from a cancer centre in Wales, UK1
European Cancer Organisation Essential Requirements for Quality Cancer Care for ovarian cancer: Focus on the multidisciplinary team1
PD-L1 testing in metastatic triple negative breast cancer: Results of an Italian survey1
Can Ki-67 predict radiotherapy response in neuroendocrine tumors? Retrospective analysis of a monocentric series of patients1
Clinical difference between solitary and multiple pulmonary adenocarcinoma nodules1
Quality of life and financial toxicity after (chemo)radiation therapy in head and neck cancer: are there any sex- or gender-related differences?1
HPV-related lesions after hysterectomy for high-grade cervical intraepithelial neoplasia and early-stage cervical cancer: A focus on the potential role of vaccination1
Effects of uniportal 3D video-assisted thoracic surgery lobectomy on postoperative pain and immune function in patients with NSCLC1
AIOM Abstract1
Clinical application and prospect of MRD evaluation in lung cancer based on ctDNA level: A review1
North-south differences in incidence and surveillance of cutaneous malignant melanoma in Italy1
Italian pediatric and adult oncology communities join forces for a national project dedicated to adolescents and young adults with cancer1
Role of radium-223 discontinuation due to adverse events in castration-resistant prostate cancer patients. A retrospective monocentric analysis1
Get up, stand up: Alongside adolescents and young adults with cancer for their right to be forgotten1
Preoperative chemo-CIRT in Re/BRe pancreatic cancer: Insights from a multicenter prospective phase II clinical study (NCT03822936)1
Cardiovascular toxicity associated with the multitargeted tyrosine kinase inhibitor anlotinib1
Management of cancer treatment–induced bone loss in patients with breast and hormone sensitive prostate cancer: AIOM survey1
Demyelinating polyradiculoneuropathy during dabrafenib and trametinib treatment for metastatic melanoma: A case report1
Hypofractionated radiotherapy for nonmelanoma skin cancer during the COVID-19 pandemic: experience in 31 cases1
Corrigendum to “Lung metastasectomy for osteosarcoma in children, adolescents, and young adults: proof of permanent cure”1
Curative treatments for colon cancer during the COVID-19 pandemic era1
Long survival of a young patient with Xp11.2 translocation metastatic clear cell renal carcinoma: case report1
A look towards the clonal origin of metastatic pulmonary carcinosarcoma: Report of a patient with an unexpected long-term survival1
Alternatively-spliced lncRNA-PNUTS promotes HCC cell EMT via regulating ZEB1 expression1
Association between clinical factors and the choice of palliative care setting among cancer patients: A post-hoc analysis of a cohort study1
The last journey, coming home before dying for migrant cancer patients: A case series1
Challenges of cancer immunotherapy and chemotherapy during the COVID-19 pandemic1
Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial1
BYL719 (alpelisib) for the treatment of PIK3CA-mutated, recurrent/advanced cervical cancer1
Fat necrosis after accelerated partial breast irradiation or hypofractionated whole breast irradiation: A case-control study1
The challenges of cascade genetic testing in hereditary cancer syndromes: A few ethical considerations1
Carbon tattooing of axillary lymph nodes in breast cancer patients before neoadjuvant chemotherapy: A retrospective analysis1
Prevalence of breast cancer in ovarian cancer patients and its impact on patient survival: An analysis of the surveillance, epidemiology, and end results data1
Mind the gap with Europe. Why public interest cannot be a good reason to perform observational and epidemiological research?1
0.059478998184204